BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1816501)

  • 1. Dextromethorphan alters cerebral blood flow and protects against cerebral injury following focal ischemia.
    Steinberg GK; Lo EH; Kunis DM; Grant GA; Poljak A; DeLaPaz R
    Neurosci Lett; 1991 Dec; 133(2):225-8. PubMed ID: 1816501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dextromethorphan on regional cerebral blood flow in focal cerebral ischemia.
    Lo EH; Steinberg GK
    J Cereb Blood Flow Metab; 1991 Sep; 11(5):803-9. PubMed ID: 1874811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dextromethorphan protects against cerebral injury following transient focal ischemia in rabbits.
    Steinberg GK; George CP; DeLaPaz R; Shibata DK; Gross T
    Stroke; 1988 Sep; 19(9):1112-8. PubMed ID: 3413809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextromethorphan attenuates post-ischemic hypoperfusion following incomplete global ischemia in the anesthetized rat.
    Tortella FC; Martin DA; Allot CP; Steel JA; Blackburn TP; Loveday BE; Russell NJ
    Brain Res; 1989 Mar; 482(1):179-83. PubMed ID: 2706475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of N-methyl-D-aspartate antagonists after focal cerebral ischemia in rabbits.
    Steinberg GK; Saleh J; Kunis D; DeLaPaz R; Zarnegar SR
    Stroke; 1989 Sep; 20(9):1247-52. PubMed ID: 2672427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dextromethorphan reduces neocortical ischemic neuronal damage in vivo.
    George CP; Goldberg MP; Choi DW; Steinberg GK
    Brain Res; 1988 Feb; 440(2):375-9. PubMed ID: 3359222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment with the NMDA antagonist dextrorphan reduces cerebral injury following transient focal ischemia in rabbits.
    Steinberg GK; Saleh J; DeLaPaz R; Kunis D; Zarnegar SR
    Brain Res; 1989 Sep; 497(2):382-6. PubMed ID: 2684345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection following focal cerebral ischaemia with the NMDA antagonist dextromethorphan, has a favourable dose response profile.
    Steinberg GK; Kunis D; DeLaPaz R; Poljak A
    Neurol Res; 1993 Jun; 15(3):174-80. PubMed ID: 8103583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parallel antioxidant and antiexcitotoxic therapy improves outcome after incomplete global cerebral ischemia in dogs.
    Davis S; Helfaer MA; Traystman RJ; Hurn PD
    Stroke; 1997 Jan; 28(1):198-204; discussion 204-5. PubMed ID: 8996512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed treatment with dextromethorphan and dextrorphan reduces cerebral damage after transient focal ischemia.
    Steinberg GK; Saleh J; Kunis D
    Neurosci Lett; 1988 Jun; 89(2):193-7. PubMed ID: 3292967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection after transient focal cerebral ischemia by the N-methyl-D-aspartate antagonist dextrorphan is dependent upon plasma and brain levels.
    Steinberg GK; Kunis D; Saleh J; DeLaPaz R
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):1015-24. PubMed ID: 1939379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextromethorphan protects against cerebral injury following transient, but not permanent, focal ischemia in rats.
    Britton P; Lu XC; Laskosky MS; Tortella FC
    Life Sci; 1997; 60(20):1729-40. PubMed ID: 9150412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of dextromethorphan against transient cerebral ischemia/reperfusion injury in gerbils.
    Ying SX; Cheng JS
    Zhongguo Yao Li Xue Bao; 1995 Mar; 16(2):133-6. PubMed ID: 7597913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotection by N-methyl-D-aspartate antagonists in focal cerebral ischemia is dependent on continued maintenance dosing.
    Steinberg GK; Yoon EJ; Kunis DM; Sun GH; Maier CM; Grant GA
    Neuroscience; 1995 Jan; 64(1):99-107. PubMed ID: 7708219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNX-111, a novel, presynaptic N-type calcium channel antagonist, is neuroprotective against focal cerebral ischemia in rabbits.
    Perez-Pinzon MA; Yenari MA; Sun GH; Kunis DM; Steinberg GK
    J Neurol Sci; 1997 Dec; 153(1):25-31. PubMed ID: 9455974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertonic saline worsens infarct volume after transient focal ischemia in rats.
    Bhardwaj A; Harukuni I; Murphy SJ; Alkayed NJ; Crain BJ; Koehler RC; Hurn PD; Traystman RJ
    Stroke; 2000 Jul; 31(7):1694-701. PubMed ID: 10884475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consistency of cerebral blood flow and evoked potential alterations with reversible focal ischemia in cats.
    Matsumiya N; Koehler RC; Traystman RJ
    Stroke; 1990 Jun; 21(6):908-16. PubMed ID: 2349595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monotherapy with dextromethorphan or tirilazad--but not a combination of both--improves outcome after transient focal cerebral ischemia in rats.
    Schmid-Elsaesser R; Zausinger S; Hungerhuber E; Baethmann A; Reulen HJ
    Exp Brain Res; 1998 Sep; 122(1):121-7. PubMed ID: 9772119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive N-methyl-D-aspartate receptor blockade reduces brain injury following transient focal ischemia in cats.
    Nishikawa T; Kirsch JR; Koehler RC; Miyabe M; Traystman RJ
    Stroke; 1994 Nov; 25(11):2258-64. PubMed ID: 7526489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of focal cerebral ischemia with synthetic oligopeptide corresponding to lectin domain of selectin.
    Morikawa E; Zhang SM; Seko Y; Toyoda T; Kirino T
    Stroke; 1996 May; 27(5):951-5; discussion 956. PubMed ID: 8623118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.